BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Diagnosis
9 results:

  • 1. [Incidence and clinical characteristics of engraftment syndrome after syngeneic hematopoietic stem cell transplantation in patients with hematological diseases].
    Lou R; Xu LP; Zhang XH; Liu KY; Wang Y; Yan CH; Huang XJ; Sun YQ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):289-294. PubMed ID: 37356997
    [No Abstract]    [Full Text] [Related]  

  • 2. Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML.
    Niederwieser C; Morozova E; Zubarovskaya L; Zabelina T; Klyuchnikov E; Janson D; Wolschke C; Christopeit M; Ayuk F; Moiseev I; Afanasyev BV; Kröger N
    Bone Marrow Transplant; 2021 Nov; 56(11):2834-2841. PubMed ID: 34331022
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.
    Solana-Altabella A; Boluda B; Rodríguez-Veiga R; Cano I; Acuña-Cruz E; Blanco A; Marco-Ayala J; de la Puerta R; Díaz-González Á; Piñana JL; Sanz J; Sempere A; Cervera J; Barragán E; Sargas C; Ballesta-López O; Megías-Vericat JE; Martínez-Cuadrón D; Sanz MÁ; Montesinos P
    Eur J Haematol; 2021 May; 106(5):724-733. PubMed ID: 33609315
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differences in diagnosis, treatment, and survival rate of acute myeloid leukemia with or without disabilities: A national cohort study in the Republic of Korea.
    Kwon J; Kim SY; Yeob KE; Han HS; Lee KH; Shin DW; Kim YY; Park JH; Park JH; Kawachi I
    Cancer Med; 2020 Aug; 9(15):5335-5344. PubMed ID: 32491262
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The impact of chronic myeloid leukemia on employment: the French prospective study.
    De Barros S; Vayr F; Despas F; Strumia M; Podevin C; Gauthier M; Delabesse E; Soulat JM; Laurent G; Huguet F; Herin F
    Ann Hematol; 2019 Mar; 98(3):615-623. PubMed ID: 30446803
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sepsis and Acute Myeloid leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas Hospitals.
    Malik IA; Cardenas-Turanzas M; Gaeta S; Borthakur G; Price K; Cortes J; Nates JL
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e27-e32. PubMed ID: 28844403
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Biomarker Dynamics in B-cell Lymphoma: A Longitudinal Prospective Study of Plasma Samples Up to 25 Years before diagnosis.
    Späth F; Wibom C; Krop EJ; Johansson AS; Bergdahl IA; Vermeulen R; Melin B
    Cancer Res; 2017 Mar; 77(6):1408-1415. PubMed ID: 28108506
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies.
    Van Gool SW; Van Kerschaver E; Brock P; Pottel H; Hulstaert F; Vanmechelen E; Uyttebroeck A; Van De Voorde A; Vanderstichele H
    Leukemia; 2000 Dec; 14(12):2076-84. PubMed ID: 11187896
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CD 45 gating correlates with bone marrow differential.
    Rainer RO; Hodges L; Seltzer GT
    Cytometry; 1995 Jun; 22(2):139-45. PubMed ID: 7587745
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.